Could focusing on the user experience reinvent drug R&D software?
Poorly designed software leads to frustrated scientists and an inefficient R&D process. The...
Trending:
-
![]()
The late-stage type 2 diabetes pipeline is dominated by ‘me-too’ drugs
-
![]()
New therapy set to dominate the HIV market
-
![]()
Experts call for a review of pharma manufacturing processes
-
![]()
Marijuana: possible solution to the opioid crisis
-
![Adocia]()
Adocia to begin trial of blood sugar regulation technology
-
![]()
AnaptysBio’s ANB-020 remains a strong potential contender in the peanut allergy market
Most Read
Company A-Z
Latest Content
Nektar and Takeda to test combination regimen for cancer
Nektar Therapeutics has entered into a clinical collaboration to investigate its NKTR-214 drug candidate in combination with Takeda Pharmaceutical’s TAK-659 for various types of cancer.
Could focusing on the user experience reinvent drug R&D software?
Poorly designed software leads to frustrated scientists and an inefficient R&D process. The Pistoia Alliance is promoting user experience principles to tackle this issue and accelerate life sciences innovation.
Weibel CDS: Safer, Easier, and Faster Drug Delivery
At the Advanced Technologies and Treatments for Diabetes (ATTD) congress in Paris, Weibel CDS showcased a presentation demonstrating its patient-centric drug delivery products, which help reduce contamination, handling errors, and needle stick injuries when administering injectable drugs.
The late-stage type 2 diabetes pipeline is dominated by ‘me-too’ drugs
Type 2 diabetes (T2D) is a chronic disease characterised by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition that is heavily influenced by diet and lifestyle.
New therapy set to dominate the HIV market
Gilead Sciences’ new HIV therapeutic Biktarvy has recently gained approval, and is expected to have a major impact on the market.
Butterworth Laboratories to Attend Making Pharmaceuticals Event
Butterworth Pharmaceuticals has announced it will be attending Making Pharmaceuticals in the Richoh Arena, Coventry.
Experts call for a review of pharma manufacturing processes
Industry experts called for a rethink of pharma industry paradigms around manufacturing orphan and cell products at DCAT Week 2018, which took place in New York City last month.
Marijuana: possible solution to the opioid crisis
In 2016, more than 110 people died every day due to opioid overdose in the US. The opioid crisis has reached epidemic levels, and the problem only seems to be growing. A solution to this epidemic is needed, and recent studies suggest that medicinal marijuana may provide some relief. Figure 1 presents the rate of opioid-related deaths in the US from 2007–2017.
Adocia to begin trial of blood sugar regulation technology
French biotech Adocia has announced the initiation of a Phase I study of BioChaperone Pramlintide Insulin, a treatment that could better regulate glucose levels in type 1 diabetes patients.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
